Liver-type fatty acid binding protein in serum and broncho-alveolar lavage in a model of acute respiratory failure because of surfactant depletion - A possible marker for lung damage?

Clinical Physiology and Functional Imaging

Volumn 26, Issue 6, 2006, Pages 371-375

  Lachmann, Robert A ^a   Werchan, S ^a   Schachtrup, C ^b   Haitsma, J J ^a   Spener, F ^b   Lachmann, B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Alveolar macrophages; Mechanical ventilation; Rat; Surfactant; Type II pneumocytes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FATTY ACID BINDING PROTEIN; LIVER TYPE FATTY ACID BINDING PROTEIN; SURFACTANT; UNCLASSIFIED DRUG;

ACUTE RESPIRATORY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG INJURY; LUNG LAVAGE; LUNG VENTILATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; RAT;

ACUTE DISEASE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD GAS ANALYSIS; BRONCHOALVEOLAR LAVAGE; CARBON DIOXIDE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; LUNG COMPLIANCE; MALE; OXYGEN; PULMONARY SURFACTANTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; TIME FACTORS;

EID: 33750135246     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2006.00703.x     Document Type: Article

References (24)

1. Amat M, Barcons M, Mancebo J, Mateo J, Oliver A, Mayoral JF, Fontcuberta J, Vila L. Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: Mortality prognostic study. Crit Care Med (2000); 28: 57-62.
2. Casey L, Krieger B, Kohler J, Rice C, Oparil S, Szidon P. Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: A preliminary report. Crit Care Med (1981); 9: 651-654.
3. Glatz JF, Kleine AH, van Nieuwenhoven FA, Hermens WT, van Dieijen-Visser MP, van der Vusse GJ. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J (1994); 71: 135-140.
4. Glatz JF, van Nieuwenhoven FA, Luiken JJ, Schaap FG, van der Vusse GJ. Role of membrane-associated and cytoplasmic fatty acid-binding proteins in cellular fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids (1997); 57: 373-378.
5. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, Nagae H, Hudson LD, Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med (1999); 160: 1843-1850.
6. Gruenwald P. A numerical index stability of lung expansion. J Appl Physiol (1963); 88: 359-367.
7. Guthmann F, Hohoff C, Fechner H, Humbert P, Borchers T, Spener F, Rustow B. Expression of fatty-acid-binding proteins in cells involved in lung-specific lipid metabolism. Eur J Biochem (1998); 253: 430-436.
8. Guthmann F, Schachtrup C, Tolle A, Wissel H, Binas B, Kondo H, Owada Y, Spener F, Rustow B. Phenotype of palmitic acid transport and of signalling in alveolar type II cells from E/H-FABP double-knockout mice: contribution of caveolin-1 and PPARgamma. Biochim Biophys Acta (2004); 1636: 196-204.
9. Haunerland NH, Spener F. Fatty acid-binding proteins-insights from genetic manipulations. Prog Lipid Res (2004); 43: 328-349.
10. van Kaam AH, de Jaegere A, Haitsma JJ, Van Aalderen WM, Kok JH, Lachmann B. Positive pressure ventilation with the open lung concept optimizes gas exchange and reduces ventilator-induced lung injury in newborn piglets. Pediatr Res (2003); 53: 245-253.
11. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem (1992); 116: 155-162.
12. Kuroki Y, Takahashi H, Chiba H, Akino T. Surfactant proteins A and D: disease markers. Biochim Biophys Acta (1998); 1408: 334-345.
13. Lachmann B, Robertson B, Vogel J. In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand (1980); 24: 231-236.
14. Lewandowski K, Metz J, Deutschmann C, Preiss H, Kuhlen R, Artigas A, Falke KJ. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am J Respir Crit Care Med (1995); 151: 1121-1125.
15. Monbaliu D, de Vries B, Crabbe T, van Heurn E, Verwaest C, Roskams T, Fevery J, Pirenne J, Buurman WA. Liver fatty acid-binding protein: An early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors. Transplant Proc (2005); 37: 413-416.
16. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, Nishimura S, Ishii H, Sunahara N, Tanaka T. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med (2000); 38: 231-238.
17. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: Prognostic and pathogenetic significance. Am J Respir Crit Care Med (1997); 155: 1187-1205.
18. Piumngam P, Schachtrup C, Owada Y, Kondo H, Promptmas C, Spener F. Expression of liver-type fatty acid-binding protein in murine lung and its release into serum upon challenge of lung with lipopolysaccharide. Eur J Lipid Sci Technol (2005); 107: 145-152.
19. Redl H, Schlag G. Lung-converting-enzyme as a possible cell-maker in connection with the ultrastructural morphology in hypovolemic-traumatic shock (author's transl). Anaesthesist (1980); 29: 552-558.
20. Sato H, Callister ME, Mumby S, Quinlan GJ, Welsh KI, duBois RM, Evans TW. KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. Eur Respir J (2004); 23: 142-145.
21. Schachtrup C, Scholzen TE, Grau V, Luger TA, Sorg C, Spener F, Kerkhoff C. L-FABP is exclusively expressed in alveolar macrophages within the myeloid lineage: Evidence for a PPARalpha-independent expression. Int J Biochem Cell Biol (2004); 36: 2042-2053.
22. Steppling H, Braun S, Nink M. Angiotensin converting enzyme in the adult respiratory distress syndrome. Schweiz Med Wochenschr (1985); 115: 202-205.
23. Verbrugge SJ, Lachmann B. Mechanisms of ventilation-induced lung injury: physiological rationale to prevent it. Monaldi Arch Chest Dis (1999); 54: 22-37.
24. Verbrugge SJ, de Jong JW, Keijzer E, Vazquez de Anda G, Lachmann B. Purine in bronchoalveolar lavage fluid as a marker of ventilation-induced lung injury. Crit Care Med (1999); 27: 779-783.